| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/09/1999 | US5869247 Natural resistance associated macrophage protein and uses thereof |
| 02/09/1999 | US5869241 Method of determining DNA sequence preference of a DNA-binding molecule |
| 02/09/1999 | US5869235 Dna coding for the coat protein of virus isolated from infected vine plants; for detection of vrial infection by reverse transcription polymerase chain reaction and southern blotting |
| 02/09/1999 | US5869233 Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS |
| 02/09/1999 | US5869232 Amino acid sequence of antibody binding to specific antigen (or hapten) covalently linked to second amino acid sequence to which a second antibody binds; redirecting specificity of antibody |
| 02/09/1999 | US5869093 Treatment of immune diseases by oral administration of autoantigens |
| 02/09/1999 | US5869092 Prevention of leakage and phase separation during thermotropic phase transition in liposomes and biological cells |
| 02/09/1999 | US5869065 Haemophilus influenzae; otitis media; sinusitis; bronchitis; dna sequences; amino acid sequences |
| 02/09/1999 | US5869064 Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| 02/09/1999 | US5869058 Genetic engineering; complexing antigen with synthetic peptide carrier |
| 02/09/1999 | US5869057 Administering a fusion protein comprising pentamers of escherichia coli labile toxin subunit b and human chorionic gonadotropin |
| 02/09/1999 | US5869055 Anti-inflammatory CD14 polypeptides |
| 02/09/1999 | US5869053 5T4 antigen from human trophoblasts |
| 02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
| 02/09/1999 | US5869049 Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists |
| 02/09/1999 | US5869048 Method of treating ulcerative colitis with a monoclonal antibody |
| 02/09/1999 | US5869047 Methods for therapeutically treating immunocomprised persons |
| 02/09/1999 | US5869045 Polypeptide comprising antigen-binding region of monoclonal antibody produced by specified hybridoma |
| 02/09/1999 | US5869043 Csbpbeta protein, cytokine suppressive anti-inflammatory drug (csaid) binding protein |
| 02/09/1999 | US5869039 X-linked adrenoleukodystrophy gene and corresponding protein |
| 02/09/1999 | US5869037 Adenoviral-mediated gene transfer to adipocytes |
| 02/09/1999 | US5869036 Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine |
| 02/09/1999 | CA1340387C Heterobifunctional coupling agents |
| 02/09/1999 | CA1340384C Methode d'utilisation de vecteurs d'expression eucaryotes comprenant un amplificateur du virus bk |
| 02/09/1999 | CA1340381C Recombinant fusion proteins |
| 02/08/1999 | CA2239223A1 Novel rpoa |
| 02/08/1999 | CA2239222A1 Novel rpoa |
| 02/06/1999 | CA2239256A1 Novel lgt |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/04/1999 | WO1999005527A2 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 02/04/1999 | WO1999005521A2 Conjugate for differentiating between healthy and unhealthy tissue |
| 02/04/1999 | WO1999005316A1 A METHOD FOR IDENTIFYING MYCOBACTERIAL SPECIES BY COMPARATIVE SEQUENCE ANALYSIS OF rpoB GENE |
| 02/04/1999 | WO1999005313A2 Method for typing of minor histocompatibility antigen ha-1 |
| 02/04/1999 | WO1999005307A1 Sel-10 AND USES THEREOF |
| 02/04/1999 | WO1999005304A1 Genetically engineered rhodococcus vaccine |
| 02/04/1999 | WO1999005302A1 Conjugates of transporter peptides and nucleic acid analogs, and their use |
| 02/04/1999 | WO1999005300A2 Ghrh expression system and methods of use |
| 02/04/1999 | WO1999005294A1 INTRACELLULAR INHIBITORS OF Gq PROTEIN SIGNALING |
| 02/04/1999 | WO1999005292A1 Method for gene screening with the use of nuclear receptors |
| 02/04/1999 | WO1999005290A1 Novel serine protease |
| 02/04/1999 | WO1999005282A1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus |
| 02/04/1999 | WO1999005281A1 Novel nucleic acid molecules and uses therefor |
| 02/04/1999 | WO1999005280A1 Mammalian cytokine: interleukin-b30 and related reagents |
| 02/04/1999 | WO1999005279A1 Mcp-1 analogs |
| 02/04/1999 | WO1999005278A1 Lens epithelial cell derived growth factor |
| 02/04/1999 | WO1999005276A1 Human chloride ion channel zsig44 |
| 02/04/1999 | WO1999005275A1 Secreted proteins encoded by human chromosome 13 |
| 02/04/1999 | WO1999005274A1 Method of identifying novel g-protein receptors and their functions |
| 02/04/1999 | WO1999005273A1 Gmeb nucleic acids, proteins, and uses thereof |
| 02/04/1999 | WO1999005272A1 Use of transcription factor brn-3a |
| 02/04/1999 | WO1999005271A1 Soluble variants of the ige receptor fc-epsilon-ri-alpha with increased affinity |
| 02/04/1999 | WO1999005270A2 Crustacean antimicrobial peptides, called penaiedines |
| 02/04/1999 | WO1999005269A2 Transcriptional silencer protein nrf |
| 02/04/1999 | WO1999005268A1 Production of erythropoietin by endogenous gene activation |
| 02/04/1999 | WO1999005267A1 Identification of human cell lines for the production of human proteins by endogenous gene activation |
| 02/04/1999 | WO1999005258A1 HUMAN Nkx POLYPEPTIDE-ENCODING NUCLEIC ACIDS AND TRANSGENIC ANIMALS DERIVED THEREFROM |
| 02/04/1999 | WO1999005255A1 Methods for enhancing or reducing preimplantation embryo survival rates |
| 02/04/1999 | WO1999005180A1 Collagen type i and type iii adhesive compositions |
| 02/04/1999 | WO1999005177A1 Methods and compositions for identifying modulators of g-protein-coupled receptors |
| 02/04/1999 | WO1999005175A2 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1) |
| 02/04/1999 | WO1999005174A1 The ha-1 antigen |
| 02/04/1999 | WO1999005173A1 The ha-1 antigen |
| 02/04/1999 | WO1999005172A2 Pharmaceuticals for modulating hormone responsiveness |
| 02/04/1999 | WO1999005171A1 NOVEL ESTROGEN RECEPTOR β AND ISOFORMS |
| 02/04/1999 | WO1999005170A1 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 02/04/1999 | WO1999005169A1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
| 02/04/1999 | WO1999005168A1 Mycobacterium strain with modified erp gene and vaccine composition containing same |
| 02/04/1999 | WO1999005167A1 Designed protein pores as components for biosensors |
| 02/04/1999 | WO1999005166A1 Hop mosaic virus gene and method for detecting hop mosaic virus |
| 02/04/1999 | WO1999005163A1 Refolding method using a foldase and a chaperone |
| 02/04/1999 | WO1999005162A1 Methods of modifying the butyrophilin protein to eliminate an autoimmune response and products associated therewith |
| 02/04/1999 | WO1999005161A1 HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR |
| 02/04/1999 | WO1999004825A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 02/04/1999 | WO1999004820A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 02/04/1999 | WO1999004815A1 Medicinal compositions with cholesterol-lowering effect |
| 02/04/1999 | WO1999004807A1 Recombinant immunotoxin containing a diphterial toxin and interleukin -2(dt482-il2) and method for preparing the same |
| 02/04/1999 | WO1999004806A1 Methods and compositions for inhibiting angiogenesis |
| 02/04/1999 | WO1999004775A2 Method of treating dopaminergic and gaba-nergic disorders |
| 02/04/1999 | WO1999004746A2 Activated forms of notch and methods based thereon |
| 02/04/1999 | WO1999004636A1 Evaluation of, delivery of, and use of agents to treat heart disorders |
| 02/04/1999 | WO1999004621A1 A molecular marker for the gene determining the fructose to glucose ratio in mature tomato fruit |
| 02/04/1999 | WO1998051337A3 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors |
| 02/04/1999 | WO1998050546A3 B cell receptor associated proteins |
| 02/04/1999 | DE19732944A1 Derivatives of calcitonin-gene-related peptide fragment |
| 02/04/1999 | DE19732926A1 New DNA encoding glucose-6-phosphate translocator from pea, maize or potato |
| 02/04/1999 | DE19732829A1 Sekretion von trägergebundenen Proteinen in das Periplasma und in den extrazellulären Raum Secretion of carrier-bound proteins in the periplasm and in the extracellular space |
| 02/04/1999 | CA2308146A1 Collagen type i and type iii adhesive compositions |
| 02/04/1999 | CA2298930A1 Pharmaceuticals for modulating hormone responsiveness |
| 02/04/1999 | CA2298887A1 The ha-1 antigen |
| 02/04/1999 | CA2298558A1 Genetically engineered rhodococcus vaccine |
| 02/04/1999 | CA2298474A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 02/04/1999 | CA2298410A1 Intracellular inhibitors of gq protein signaling |
| 02/04/1999 | CA2298114A1 Human chloride ion channel zsig44 |
| 02/04/1999 | CA2298107A1 Use of transcription factor brn-3a |
| 02/04/1999 | CA2298103A1 Non-b, non-c, non-g hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 02/04/1999 | CA2298067A1 Conjugates of transporter peptides and nucleic acid analogs, and their use |
| 02/04/1999 | CA2298063A1 Mycobacterium strain with modified erp gene and vaccine composition containing same |
| 02/04/1999 | CA2298053A1 Novel estrogen receptor .beta. and isoforms |
| 02/04/1999 | CA2298015A1 Production of erythropoietin by endogenous gene activation |
| 02/04/1999 | CA2297946A1 Sel-10 and uses thereof |